<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Long-term neuroprotection by <z:chebi fb="0" ids="6015">isoflurane</z:chebi> has been questioned </plain></SENT>
<SENT sid="1" pm="."><plain>The authors examined factors in experimental models potentially critical to definition of enduring <z:chebi fb="0" ids="6015">isoflurane</z:chebi> neuroprotection </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Rats were prepared for temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>Pericranial normothermia was maintained </plain></SENT>
<SENT sid="4" pm="."><plain>Neurologic deficits (range, 0-48; 0=no deficit) and cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were measured </plain></SENT>
<SENT sid="5" pm="."><plain>In experiment 1, rats underwent 50 or 80 min MCAO while awake or anesthetized with 1.8% <z:chebi fb="0" ids="6015">isoflurane</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Blood pressure was controlled with <z:chebi fb="0" ids="8093">phenylephrine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Outcome was evaluated 2 weeks later </plain></SENT>
<SENT sid="8" pm="."><plain>In experiment 2, rats underwent 50 min MCAO while awake or anesthetized with <z:chebi fb="0" ids="6015">isoflurane</z:chebi>, with outcome evaluated 8 weeks later </plain></SENT>
<SENT sid="9" pm="."><plain>In experiment 3, rats underwent 50 min MCAO while awake or anesthetized with <z:chebi fb="0" ids="6015">isoflurane</z:chebi> and 2 weeks recovery </plain></SENT>
<SENT sid="10" pm="."><plain>Effects of <z:chebi fb="0" ids="8093">phenylephrine</z:chebi> and the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="3" ids="15422">adenosine triphosphate</z:chebi>-sensitive K channel <z:chebi fb="68" ids="48706">antagonist</z:chebi> 5-hydroxydecanoate were studied </plain></SENT>
<SENT sid="11" pm="."><plain>In experiment 4, <z:chebi fb="0" ids="6015">isoflurane</z:chebi>-anesthetized rats underwent 50 min MCAO with permanent or temporary common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp>, with outcome evaluated 2 weeks later </plain></SENT>
<SENT sid="12" pm="."><plain>RESULTS: In experiment 1, <z:chebi fb="0" ids="6015">isoflurane</z:chebi> reduced neurologic deficit (median+/-interquartile range; awake vs. <z:chebi fb="0" ids="6015">isoflurane</z:chebi>: 11+/-12 vs. 8+/-6 for 80 min and 13+/-4 vs. 3+/-9 for 50 min; P=0.0006) and <z:mpath ids='MPATH_124'>infarct</z:mpath> size (160+/-97 vs. 84+/-62 mm for 80 min and 169+/-78 vs. 68+/-61 mm for 50 min; P&lt;0.0001) </plain></SENT>
<SENT sid="13" pm="."><plain>In experiment 2, <z:chebi fb="0" ids="6015">isoflurane</z:chebi> protection persisted at 8 weeks after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>In experiment 3, there was no effect of <z:chebi fb="0" ids="8093">phenylephrine</z:chebi> or 5-hydroxydecanoate </plain></SENT>
<SENT sid="15" pm="."><plain>In experiment 4, permanent common carotid ligation increased <z:mpath ids='MPATH_124'>infarct</z:mpath> size threefold versus temporary occlusion </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="6015">Isoflurane</z:chebi> repeatedly improved long-term neurologic and histologic outcome from focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> independent of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> duration, perfusion pressure, or pretreatment with 5-hydroxydecanoate </plain></SENT>
</text></document>